Takeda Pharmaceutical Growth Metrics (2019-2025) | TAK

Growth Metrics Mar2019 Mar2020 Mar2021 Mar2022 Mar2023 Mar2024 Mar2025
Growth Ratios
Cash & Equivalents Growth (1y) 134.71%-8.17%55.88%-19.90%-44.83%-23.41%-18.29%
Cash & Equivalents Growth (3y) 49.77%4.66%-11.69%-30.31%-29.85%
Cash & Equivalents Growth (5y) 8.22%-13.50%-15.49%
Enterprise Value Growth (1y) 1,530.19%-16.14%14.22%-21.45%25.96%-13.90%10.13%
Enterprise Value Growth (3y) 150.40%-9.05%4.16%-5.20%6.10%
Enterprise Value Growth (5y) 73.13%-3.99%1.39%
Property, Plant & Equipment (Net) Growth (1y) 79.39%-35.42%7.88%-0.85%-6.12%5.01%-3.92%
Property, Plant & Equipment (Net) Growth (3y) 7.71%-11.60%0.14%-0.76%-1.79%
Property, Plant & Equipment (Net) Growth (5y) 3.07%-7.40%0.26%
Shareholder's Equity Growth (1y) 153.10%-7.83%12.65%0.03%-1.81%2.17%-7.38%
Shareholder's Equity Growth (3y) 38.00%1.27%3.43%0.12%-2.42%
Shareholder's Equity Growth (5y) 20.88%0.83%0.92%
Total Debt Growth (1y) 457.72%-10.45%-1.82%-18.58%-11.40%-1.35%-9.45%
Total Debt Growth (3y) 69.89%-10.55%-10.86%-10.72%-7.50%
Total Debt Growth (5y) 28.75%-8.95%-8.75%